SCHEMBL7986783

SCHEMBL7986783

COc1cc2nc(Nc3c(C)cccc3Cl)c3cncn3c2cc1N1CCNCC1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7970156 0.98 LCK (0.73) LCK
SCHEMBL7981242 0.88 LCK (0.74) LCK
SCHEMBL7983578 0.87 LCK (1.00) LCK
SCHEMBL7983576 0.87 LCK (1.00) LCK
SCHEMBL7970084 0.86 LCK (1.00) LCK
SCHEMBL8663023 0.86 LCK (0.58) LCK
SCHEMBL7986880 0.85 LCK (1.00) LCK
SCHEMBL7970031 0.85 LCK (0.78) LCK
SCHEMBL7981233 0.84 LCK (0.95) LCK
SCHEMBL7981234 0.84 LCK (0.95) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO disclosed